AVY vs H

The Advanced Deterministic Scorecard shows a Piotroski F-Score of 4/9, indicating stable but not strong financial health, while the absence of an Altman Z-Score prevents a definitive bankruptcy risk assessment. Despite solid profitability metrics like a 30.21% ROE and manageable 41.32% payout ratio, weak earnings growth and a bearish technical trend weigh on momentum. Valuation appears stretched relative to Graham’s defensive benchmark of $75.48, though forward P/E of 17.99 suggests some optimism. Analysts recommend a buy with a $206.80 target, implying 10.3% upside, but recent price performance has been flat over the past year.

Hyatt Hotels Corporation presents a stark contrast between strong top-line growth and poor fundamental health, evidenced by a weak Piotroski F-Score of 2/9. While revenue growth is robust at 17.5% YoY and analysts maintain a 'Buy' rating with a target of $185.44, the company's negative profit margin (-1.50%) and low current ratio (0.75) signal liquidity and efficiency risks. The valuation is premium with a Forward P/E of 35.28, though a PEG of 1.09 suggests this is partially supported by growth. Overall, the bullish analyst sentiment is countered by bearish insider activity and deteriorating deterministic health metrics.